| Title | Fusion Biopsy Market to Hit USD 0.91 Billion by 2029 |
|---|
| URL | https://www.prnewswire.com/news-releases/fusion-biopsy-market-to-hit-usd-0-91-billion-by-2029-with-7-1-cagr--marketsandmarkets-302331143.html |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Fusion Biopsy Market |
|---|
| Meta Description | The fusion biopsy market is highly consolidated, with top companies holding significant market shares. The top three players in this market include Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), and KOELIS (France). |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The global fusion biopsy market is anticipated to grow from USD 0.65 billion in 2024 to USD 0.91 billion by 2029, at a compound annual growth rate of 7.1%. Some main drivers for the growth of the fusion biopsy market are the growing prevalence of prostate cancer, since it's among one of the most common serious health concerns for males on a global scale. Fusion biopsy can be considered to be at the forefront in capitalizing on this demand for effective diagnostic solutions that are minimally invasive, as this can couple MRI and ultrasound imaging together for precise targeting of suspicious-appearing lesions. |
